Neonatal Sepsis Antibiotic Protocol: NNF India Empiric Therapy Guidelines for NICU
Neonatal Sepsis: A Leading Cause of Neonatal Mortality in India
Neonatal sepsis remains the third leading cause of neonatal death in India, accounting for approximately 16% of all neonatal mortality. The National Neonatology Forum (NNF) of India estimates that the incidence of neonatal sepsis ranges from 30-170 per 1000 live births in hospital settings, significantly higher than global averages. Early recognition and appropriate empiric antibiotic therapy are the cornerstones of management, while antimicrobial stewardship prevents the escalating crisis of multidrug-resistant organisms in Indian NICUs.
Classification: Early-Onset vs Late-Onset Sepsis
Neonatal sepsis is classified based on the timing of onset, which reflects different pathogenic mechanisms and causative organisms:
| Feature | Early-Onset Sepsis (EOS) | Late-Onset Sepsis (LOS) |
|---|---|---|
| Timing | Within 72 hours of birth | After 72 hours of life |
| Source | Maternal genital tract (vertical transmission) | Nosocomial or community-acquired (horizontal) |
| Common organisms | GBS, E. coli, Listeria, Klebsiella | CoNS, Klebsiella, Acinetobacter, MRSA, Candida |
| Risk factors | PROM >18 hrs, maternal fever, chorioamnionitis, preterm birth | Prematurity, central lines, prolonged NICU stay, prior antibiotics |
| Mortality | 15-30% in preterm | 10-20% depending on organism |
Indian-Specific Microbiological Patterns
Unlike Western data where Group B Streptococcus dominates EOS, Indian NICUs report a higher prevalence of gram-negative organisms, particularly Klebsiella pneumoniae, Escherichia coli, and Acinetobacter species, even in early-onset disease. This difference influences empiric antibiotic selection in Indian settings. NNF surveillance data from the DeNIS collaboration (Delhi Neonatal Infection Study) has been instrumental in defining Indian neonatal pathogen profiles and resistance patterns.
Empiric Antibiotic Protocol for Early-Onset Sepsis
When EOS is suspected based on clinical signs (temperature instability, respiratory distress, lethargy, poor feeding, hypotension) or risk factors, empiric antibiotics should be initiated within one hour of clinical suspicion, ideally after obtaining blood cultures.
First-Line EOS Regimen (NNF India Recommended)
| Drug | Dose | Route | Frequency | Coverage |
|---|---|---|---|---|
| Ampicillin | 50 mg/kg/dose | IV | q12h (day 0-7); q8h (day 8+) | GBS, Listeria, Enterococcus |
| Gentamicin | 4-5 mg/kg/dose | IV over 30 min | q24-36h based on GA | Gram-negatives (synergy with ampicillin) |
Gentamicin Dosing by Gestational Age
| Gestational Age | Postnatal Age | Dose (mg/kg) | Interval |
|---|---|---|---|
| Less than 30 weeks | 0-14 days | 5 | Every 48 hours |
| 30-34 weeks | 0-7 days | 4.5 | Every 36 hours |
| 35 weeks and above | 0-7 days | 4 | Every 24 hours |
Empiric Antibiotic Protocol for Late-Onset Sepsis
LOS empiric therapy must account for the nosocomial flora of the individual NICU. Units with high rates of gram-negative multidrug resistance may need broader initial coverage. However, the principle of starting narrow and escalating based on culture results remains fundamental.
Suggested LOS Regimens by Clinical Scenario
| Scenario | First-Line Regimen | Alternative |
|---|---|---|
| Community-acquired LOS | Ampicillin + Gentamicin | Cefotaxime + Amikacin |
| Hospital-acquired LOS | Piperacillin-Tazobactam + Amikacin | Cefepime + Amikacin |
| Suspected MRSA | Vancomycin + Cefotaxime | Vancomycin + Amikacin |
| Suspected fungal sepsis | Fluconazole (6 mg/kg loading, then 3 mg/kg/day) | Amphotericin B (1 mg/kg/day) |
| MDR gram-negative suspected | Meropenem + Amikacin | Colistin (last resort) |
Culture-Based De-escalation and Escalation
The cornerstone of antimicrobial stewardship in neonatal sepsis is culture-driven therapy adjustment at 48-72 hours. NNF India guidelines mandate the following decision algorithm:
- Blood culture positive: Narrow antibiotic spectrum to target the identified organism based on sensitivity profile
- Blood culture negative at 48-72 hours with clinical improvement: Discontinue antibiotics if CRP is trending down and clinical status is stable
- Blood culture negative but clinical deterioration: Consider CSF analysis, urine culture, and imaging; escalate to second-line agents
- Culture-positive with resistant organism: Escalate per sensitivity; consult infectious disease if available
Antimicrobial Stewardship Alert: The NNF India Antibiotic Policy emphasizes that prolonged empiric antibiotics (beyond 5 days without culture confirmation) are associated with increased risk of NEC, invasive candidiasis, and death in preterm neonates. Every day of unnecessary antibiotics carries measurable harm.
Key Drug Dosing Reference for Neonatal Sepsis
| Drug | Dose | Route | Frequency | Key Monitoring |
|---|---|---|---|---|
| Ampicillin | 50 mg/kg (100 mg/kg for meningitis) | IV | q12h (0-7d); q8h (8d+) | Renal function |
| Gentamicin | 4-5 mg/kg | IV | q24-48h (by GA) | Trough levels, renal function, audiometry |
| Cefotaxime | 50 mg/kg | IV | q8-12h | Hepatic function |
| Vancomycin | 15 mg/kg | IV over 60 min | q8-12h (by GA) | Trough levels (target 10-15 mcg/mL), renal |
| Meropenem | 20 mg/kg (40 mg/kg for meningitis) | IV | q8-12h | Seizure threshold, renal function |
| Piperacillin-Tazobactam | 80 mg/kg (piperacillin component) | IV | q8-12h | Hepatic function, coagulation |
| Amikacin | 15 mg/kg | IV | q24-48h (by GA) | Trough levels, renal, audiometry |
| Fluconazole | 6 mg/kg load, then 3 mg/kg/day | IV/PO | q24-72h (by GA) | Hepatic function, drug interactions |
Sepsis Screening and Biomarkers
Accurate diagnosis guides appropriate antibiotic use. The sepsis screening workup in Indian NICUs should include:
- Blood culture: Minimum 1 mL in a single aerobic bottle; two-site cultures preferred for LOS
- Complete blood count with differential: Low total WBC (below 5000/mm3), immature-to-total neutrophil ratio above 0.2, and thrombocytopenia are suggestive
- C-reactive protein (CRP): Serial measurements at 0 and 24-48 hours; sensitivity improves with repeat testing
- Procalcitonin (PCT): More specific than CRP for bacterial infection; useful for de-escalation decisions
- Micro-ESR: Elevated above 15 mm in first hour supports sepsis diagnosis in resource-limited settings
- Lumbar puncture: Mandatory in all cases of proven bacteremia, meningitis symptoms, or clinical deterioration
Special Considerations for Preterm and VLBW Neonates
Very low birth weight (VLBW, below 1500 g) neonates face disproportionately higher sepsis risk and require adjusted pharmacokinetics:
- Extended dosing intervals: Aminoglycosides require longer intervals (every 36-48 hours) due to immature renal clearance
- Therapeutic drug monitoring: Mandatory for vancomycin and aminoglycosides in VLBW neonates
- Fungal prophylaxis: Fluconazole prophylaxis (3 mg/kg twice weekly) is recommended for ELBW neonates in units with high candidiasis rates per NNF guidelines
- Central line management: Strict aseptic technique for PICC and UVC maintenance is the most effective measure for preventing LOS
Indian NICU Antibiogram Development
Every Indian NICU should develop and update a local antibiogram annually. This document tracks the sensitivity patterns of common neonatal pathogens isolated in that specific unit. HEAMAC neonatal care resources advocate for standardized antibiogram templates that can be easily maintained even in smaller Level II units. A good antibiogram guides empiric therapy selection, tracks resistance trends, and forms the backbone of an effective antibiotic stewardship program. The NNF Infectious Diseases Chapter provides annual surveillance summaries that individual units can benchmark against.
Duration of Antibiotic Therapy
| Condition | Recommended Duration | Notes |
|---|---|---|
| Suspected sepsis, culture negative | 48-72 hours | Stop if clinically well and CRP normal |
| Proven bacteremia (uncomplicated) | 7-10 days | From first negative culture |
| Neonatal meningitis (gram-positive) | 14 days | Repeat LP at 48 hours for clearance |
| Neonatal meningitis (gram-negative) | 21 days | Or 14 days after CSF sterilization |
| Neonatal osteomyelitis or arthritis | 4-6 weeks | Transition to oral if culture-sensitive agent available |
| Invasive candidiasis | 14 days minimum | After last positive culture; longer for deep organ involvement |
Conclusion: Balancing Urgency with Stewardship
Neonatal sepsis in India demands a dual approach: immediate, aggressive empiric therapy to save lives, combined with disciplined antimicrobial stewardship to preserve the efficacy of available antibiotics. Every Indian NICU, from Level II SNCUs to Level III tertiary centers, must have a written antibiotic policy, regularly updated antibiogram, and a culture of early de-escalation. The NNF India sepsis protocols, combined with WHO and AAP guidelines, provide a robust framework that reduces mortality while combating the growing threat of antimicrobial resistance.